Alliance-driven governance: Applying a global commodity chains approach to the U.K. biotechnology industry

Economic Geography

Volumn 84, Issue 1, 2008, Pages 83-103

  Birch, Kean ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Alliance driven governance; Biotechnology; Clusters; Global commodity chains; Global production networks

Indexed keywords

BIOTECHNOLOGY; CLUSTER ANALYSIS; COMMODITY; INDUSTRIAL ENTERPRISE; INDUSTRIAL LINKAGE; INNOVATION;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 42049097871     PISSN: 00130095     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1944-8287.2008.tb00392.x     Document Type: Article

References (101)

1. ACARD, ABRC, and the Royal Society. 1980. Biotechnology: Report of a joint working party [aka The Spinks report]. London: Her Majesty's Stationery Office.
2. Amin, A., and Thrift, N. 1992. Neo-Marshallian nodes in global networks. International Journal of Urban and Regional Research 16:571-87.
3. Arora, A., and Merges, R. 2004. Specialized supply firms, property rights and firm boundaries. Industrial and Corporate Change 13:451-75.
4. Arundel, A., and Mintzes, B. 2004. The benefits of biopharmaceuticals. Working Paper No. 14, ESRC Innogen Centre, Edinburgh.
5. Asheim, B.; Cooke, P.; and Martin, R., eds. 2006. Clusters and regional development: Critical reflections and explorations. London: Routledge.
6. Asheim, B., and Gertler, M. 2005. The geography of innovation: Regional innovation systems. In The Oxford handbook of innovation, ed. J. Fagerberg, D. Mowery, and R. Nelson, 291-317. Oxford, U.K.: Oxford University Press.
7. Audretsch, D. 2003. The role of small firms in US biotechnology clusters. In Biotechnology in comparative perspective, ed. G. Fuchs, 14-32. London: Routledge.
8. Bagchi-Sen, S.; Lawton Smith, H.; and Hall, L. 2004. The US biotechnology industry: Industry dynamics and policy. Environment and Planning C 22:199-216.
9. Bair, J. 2005. Global capitalism and commodity chains: Looking back, going forward. Competition and Change 9:153-80.
10. Bair, J., and Gereffi, G. 2001. Local clusters in global chains: The causes and consequences of export dynamism in Torreon's blue jeans industry. World Development 29:1885-903.
11. Bathelt, H.; Malmberg, A.; and Maskell, P. 2004. Clusters and knowledge: Local buzz, global pipelines and the process of knowledge creation. Progress in Human Geography 28:31-56.
12. Bioscience Innovation and Growth Team (BIGT). 2003. Improving notional health, improving national wealth. London: BIGT.
13. Birch, K. 2006. Biotechnology value chains as a case study of the knowledge economy: The relationship between knowledge, space and technology. Unpublished Ph.D. thesis, Department of Planning, Oxford Brookes University, Oxford, U.K.
14. Birch, K. 2007a. Knowledge, space and biotechnology. Geography Compass 1:1097-117.
15. Birch, K. 2007b. The social construction of the biotech industry. In New genetics, new social formations, ed. P. Glasner, P. Atkinson, and H. Greenslade, 94-113. London: Routledge.
16. Boschma, R. 2005. Proximity and innovation: A critical assessment. Regional Studies 39:61-74.
17. Breschi, S.; Lissoni, F.; and Orsenigo, L. 2003. Success and failure in the development of biotechnology clusters: The case of Lombardy. In Comparing the development of biotechnology clusters, ed. G. Fuchs, 143-68. London: Harwood Academic.
18. Brown, G. 2005. Global Europe: Full-employment Europe. London: Her Majesty's Treasury.
19. Bud, R. 1993. The uses of life: A history of biotechnology. Cambridge, U.K.: Cambridge University Press.
20. Bunnell, T., and Coe, N. 2001. Spaces and scales of innovation. Progress in Human Geography 25:569-89.
21. Casper, S., and Karamanos, A. 2003. Commercializing science in Europe: The Cambridge biotechnology cluster. European Planning Studies 11:805-22.
22. Casper, S., and Kettler, H. 2001. National institutional frameworks and the hybridization of entrepreneurial business models: The German and UK biotechnology sectors. Industry and Innovation 8:5-30.
23. Casper, S., and Murray, F. 2004. Examining the marketplace for ideas: How local are Europe's biotechnology clusters? In The economic dynamic of modern biotechnology, ed. M. McKelvey, A. Rickne, and J. Laage-Hellman, 326-55. Cheltenham, U.K.: Edward Elgar.
24. Coe, N.; Hess, M.; Yeung, H.; Dicken, P.; and Henderson, J. 2004. "Globalizing" regional development: A global production networks perspective. Transactions of the Institute of British Geographers NS 29:468-84.
25. Coenen, L.; Moodysson, J.; and Asheim, B. 2004. Nodes, networks and proximities: On the knowledge dynamics of the Medicon Valley biotech cluster. European Planning Studies 12:1003-18.
26. Cooke, P. 2001. Biotechnology clusters in the UK: Lessons from localisation in the commercialisation of science. Small Business Economics 17:43-59.
27. Cooke, P. 2002. Regional science policy and the growth of knowledge megacentres in bioscience clusters. Paper presented at the 42nd Congress of the European Regional Science Association, Dortmund, Germany, 27-31 August.
28. Cooke, P. 2004a. The molecular biology revolution and the rise of bisocience megacentres in North America and Europe. Environment and Planning C 22:161-77.
29. Cooke, P. 2004b. Life sciences clusters and regional science policy. Urban Studies 41:1113-31.
30. Cooke, P. 2004c. Regional knowledge capabilities, embeddedness of firms and industry organisation: Bioscience megacentres and economic geography. European Planning Studies 12:625-41.
31. Cooke, P. 2005. Regionally asymmetric knowledge capabilities and open innovation: Exploring "Globalisation 2" - A new model of industry organization. Research Policy 34:1128-49.
32. Cooke, P., and Leydesdorff, L. 2006. Regional development in the knowledge-based economy: The construction of advantage. Journal of Technology Transfer 31:5-15.
33. Department of the Environment, Transport and the Regions (DETR). 2000. Planning for clusters: A research report. London: DETR.
34. Department of Trade and Industry (DTI). 1998. Our competitive future: White paper. London: DTI.
35. Department of Trade and Industry (DTI). 1999a. Biotechnology clusters report. London: DTI.
36. Department of Trade and Industry (DTI). 1999b. Genome Valley: The economic potential and strategic importance of biotechnology in the UK. London: DTI.
37. Department of Trade and Industry (DTI). 1999c. Our competitive future: The economics of the knowledge driven economy. Papers presented at a conference jointly organized by the DTI and CEPR, 27 January 1999, London.
38. Department of Trade and Industry (DTI). 2003. Innovation report - Competing in the global economy. The innovation challenge. London: DTI.
39. Department of Trade and Industry (DTI). 2005. Comparative statistics for the UK, European and US biotechnology sectors: Analysis year 2003. London: DTI
40. Dodgson, M. 1993a. Learning, trust and technological collaboration. Human Relations 46:77-95.
41. Dodgson, M. 1993b. Technological collaboration in industry. London: Routledge.
42. Ernst, D. 2002. Global production networks and the changing geography of innovation systems: Implications for developing countries. Economics of Innovation and New Technology 11:497-523.
43. Ernst, D., and Kim, L. 2002. Global production networks, knowledge diffusion, and local capability formation. Research Policy 31:1417-29.
44. Ernst & Young International. 2005. Beyond borders: Global biotechnology report 2005. London: Ernst & Young International.
45. Fagerberg, J. 2005. Innovation: A guide to the literature. In The Oxford handbook of innovation, ed. J. Fagerberg, D. Mowery, and R. Nelson, 1-26. Oxford, U.K.: Oxford University Press.
46. Fairtlough, G. 1989. Exploitation of biotechnology in a smaller company. Philosophical Transactions of the Royal Society of London: Series B 324:589-97.
47. Faulkner, W. 1992. Book review: When is small beautiful in biotech? Social Studies of Science 22:586-89.
48. Feldman, M., and Francis, J. 2003. Fortune favours the prepared region: The case of entrepreneurship and the Capitol region biotechnology cluster. European Planning Studies 11:765-88.
49. Food and Drug Administration (FDA). 2004. Innovation or stagnation? Rockville, Md.: FDA.
50. Fuchs, G., and Krauss, G. 2003. Biotechnology in comparative perspective. In Biotechnology in Comparative Perspective, ed. G. Fuchs, 1-13. London: Routledge.
51. Gereffi, G. 1994. The organization of buyer-driven global commodity chains: How U.S. retailers shape overseas production networks. In Commodity chains and global capitalism, ed. G. Gereffi and M. Korzeniewicz, 95-122. Westport, Conn.: Greenwood Press.
52. Gereffi, G. 1996. Global commodity chains: New forms of coordination and control among nations and firms in international industries. Competition and Change 1:427-39.
53. Gereffi, G. 1999. A commodity chain framework for analyzing global industries. IDS, University of Sussex. Available online: http:// www.ids.ac.uk/ids/global/pdfs/gereffi.pdf
54. Gereffi, G. 2001. Beyond the producer-driven/buyer-driven dichotomy. IDS Bulletin 32:30-40.
55. Gereffi, G.; Humphrey, J.; and Sturgeon, T. 2005. The governance of global value chains. Review of International Political Economy 12:78-104.
56. Gertler, M., and Levitte, Y. 2005. Local nodes in global networks: The geography of knowledge flows in biotechnology innovation. Industry and Innovation 12:487-507.
57. Gray, M., and Parker, E. 1998. Industrial change and regional development: The case of the US biotechnology and pharmaceutical industries. Environment and Planning A 30:1757-74.
58. Hassink, R. 2005. How to unlock regional economies from path dependency? From learning regions to learning cluster. European Planning Studies 13:521-35.
59. Henderson, J.; Dicken, P.; Hess, M.; Coe, N.; and Yeung, H. 2002. Global production networks and the analysis of economic development. Review of International Political Economy 9:436-64.
60. Her Majesty's Treasury. 2001. Productivity in the UK: The regional dimension. London: Her Majesty's Treasury.
61. Her Majesty's Treasury. 2003. Lambert review of business-university collaboration. London: Her Majesty's Stationery Office.
62. Hess, M., and Yaung, H. 2006. Guest editorial: Wither global production networks in economic geography. Environment and Planning A 38:1193-204.
63. Hopkins, M.; Martin, P.; Nightingale, P.; Kraft, A.; and Mahdi, S. 2007. The myth of the biotech revolution: An assessment of technological, clinical and organisational change. Research Policy 36:566-89.
64. Joppi, R.; Bertele, V.; and Garattini, S. 2005. Disappointing biotech. British Medical Journal 331:895-97.
65. Lawton Smith, H.; Mihell, D.; and Kingham, D. 2000. Knowledge-complexes and the locus of technological change: The biotechnology sector in Oxfordshire. Area 32:179-88.
66. Leibovitz, J. 2004. "Embryonic" knowledge-based clusters and cities: The case of biotechnology in Scotland. Urban Studies 41:1133-55.
67. Malmberg, A. 2003. Beyond the cluster - Local milieus and global connections. In Remaking the global economy, ed. J. Peck and H. Yeung, 145-59. London: Sage.
68. Malmberg, A., and Maskell, P. 2006. Localized learning revisited. Growth and Change 37:1-18.
69. Malmberg, A., and Power, D. 2005. (How) do (firms in) clusters create knowledge? Industry and Innovation 12:409-31.
70. Markusen, A. 1996. Sticky places in slippery spaces: A typology of industrial districts. Economic Geography 72:293-313.
71. Massey, D. 1995. Spatial divisions of labour. London: Macmillan.
72. McKelvey, M. 2004. Evolutionary economics perspectives on the regional-national-international dimensions of biotechnology innovations. Environment and Planning C 22:179-97.
73. McKelvey, M.; Rickne, A.; and Laage-Hellman, J. 2004. Stylized facts about innovation processes in modern biotechnology. In The economic dynamic of modern biotechnology, ed. M. McKelvey, A. Rickne, and J. Laage-Hellman, 43-75. Cheltenham, U.K.: Edward Elgar.
74. McNamara, P., and Baden-Fuller, C. 1999. Lessons from the Celltech case: Balancing knowledge exploration and exploitation in organizational renewal. British Journal of Management 10:291-307.
75. Nightingale, P., and Martin, P. 2004. The myth of the biotech revolution. Trends in Biotechnology 22:564-69.
76. OECD. 1996. The knowledge-based economy. Paris: Organization for Economic Cooperation and Development.
77. Office of the Deputy Prime Minister (ODPM). 2004 [2000]. Our towns and cities: The future. London: ODPM.
78. Orsi, F., and Coriat, B. 2005. Are "strong patents" beneficial to innovative activities? Lessons from the genetic testing for breast cancer controversies. Industrial and Corporate Change 14:1205-21.
79. Ossenbrügge, J., and Zeller, C. 2002. The biotech region of Munich and the spatial organisation of its innovation networks. In Technological change and regional development in Europe, ed. L. Schätzl and J. Diez Revilla, 233-49. Berlin: Physicia-Verlag.
80. Owen, G. 2004. Where are the big gorillas? High technology entrepreneurship in the UK and the role of public policy. London: Diebold Institute for Public Policy Studies.
81. Parr, J. 2002. Agglomeration economies: Ambiguities and confusions. Environment and Planning A 34:717-31.
82. Phelps, N. 2004. Clusters, dispersion and the spaces in between: For an economic geography of the banal. Urban Studies 41:971-89.
83. Pisano, G. 2006. Can science be a business? Lessons from biotech. Harvard Business Review 84:114-25.
84. Porter, M. 1990. The competitive advantage of nations. London: Macmillan.
85. Porter, M. 2000. Location, competition, and economic development: Local clusters in a global economy. Economic Development Quarterly 14:15-34.
86. Prevezer, M. 2001. Ingredients in the early development of the US biotechnology industry. Small Business Economics 17:17-29.
87. Prevezer, M. 2003. The development of biotechnology clusters in the USA from the late 1970s to the early 1990s. In Biotechnology in comparative perspective, ed. G. Fuchs, 33-55. London: Routledge.
88. Rader, R. 2003. BIOPHARMA: Biopharmaceutical products in the US market. Rockville, Md.: Biotechnology Information Institute.
89. Ryan, C., and Phillips, P. 2004. Knowledge management in advanced technology industries: An examination of international agricultural biotechnology clusters. Environment and Planning C 22:217-32.
90. Senker, J. 2005. Biotechnology alliances in the European pharmaceutical industry: Post, present and future. Sussex European Papers No. 137, University of Sussex, Science Policy Research Unit, Brighton, United Kingdom.
91. Sharp, M. 1985. The new biotechnology: European governments in search of a strategy. Sussex European Papers No. 15, University of Sussex, Science Policy Research Unit, Brighton, United Kingdom.
92. Sharp, M., and Senker, J. 1999. European biotechnology: Learning and catching-up. In The Organization of Economic Innovation in Europe, ed. A. Gambardella and F. Malerba, 269-302. Cambridge, U.K.: Cambridge University Press.
93. Simmie, J. 2004. Innovation and clustering in the globalised international economy. Urban Studies 41:1095-112.
94. Smith, A.; Rainnie, A.; Dunford, M.; Hardy, J.; Hudson, R.; and Sadler, D. 2002. Networks of value, commodities and regions: Reworking divisions of labour in macro-regional economies. Progress in Human Geography 26:41-63.
95. Sokol, M. 2004. The "knowledge economy": A critical view. In Regional economies as knowledge laboratories, ed. P. Cooke and A. Piccaluga, 216-31. Cheltenham, U.K.: Edward Elgar.
96. Sturgeon, T. 2001. How do we define value chains and production networks? IDS Bulletin 32:9-18.
97. Timmons, H. 2004. Belgian drug maker seeks to buy Celltech. New York Times, 19 May. Available online: http://query.nytimes.com/gst/ fullpage.html?res=950CE2DC123FF93AA25756C0A9629C8B63&sec= &spon=&pagewanted=all
98. Vallance, P. 2007. Rethinking economic geographies of knowledge. Geography Compass 1:797-813.
99. Whitley, R. 1996. Business systems and global commodity chains: Competing or complementary forms of economic organisation. Competition and Change 1:411-25.
100. Zeller, C. 2001. Clustering biotech: A recipe for success? Spatial patterns of growth of biotechnology in Munich, Rhineland and Hamburg. Small Business Economics 17:123-41.
101. Zeller, C. 2004. North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas. Economic Geography 80:83-111.